COLUMBIA, Md., April 28 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at Deutsche Bank Securities' 33rd Annual Health Care Conference in Boston, MA. The conference is being held May 5 - 7, 2008 at the InterContinental Boston. Martek CEO Steve Dubin will be presenting on Wednesday, May 7th, 2008 at 8:10 a.m. Eastern Time.
A live audio webcast of Martek's presentation can be accessed at: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=MATK&item_id=1827532
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.
Contact: Kyle Stults
SOURCE Martek Biosciences Corporation